Akari Therapeutics Ownership 2024 | Who Owns Akari Therapeutics Now?
Institutional Ownership
0.26%
Insider Ownership
38.21%
Retail Ownership
61.52%
Institutional Holders
2.00
Akari Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SABBY MANAGEMENT, LLC | - | - | - | -164,026 | -100.00% | - | Mar 31, 2024 |
CORNERSTONE PLANNING GROUP LLC | - | - | - | -5 | -100.00% | - | Mar 31, 2024 |
Akari Therapeutics's largest institutional shareholder is SABBY MANAGEMENT, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SABBY MANAGEMENT, LLC | - | - | - | -164,026 | -100.00% | - | Mar 31, 2024 |
CORNERSTONE PLANNING GROUP LLC | - | - | - | -5 | -100.00% | - | Mar 31, 2024 |
The largest Akari Therapeutics shareholder by % of total assets is SABBY MANAGEMENT, LLC. The company owns 0.00 shares of Akari Therapeutics (AKTX), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CORNERSTONE PLANNING GROUP LLC | - | - | - | -5 | -100.00% | - | Mar 31, 2024 |
SABBY MANAGEMENT, LLC | - | - | - | -164,026 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Akari Therapeutics's largest institutional buyer is CORNERSTONE PLANNING GROUP LLC. The company purchased -5.00 stocks of AKTX, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SABBY MANAGEMENT, LLC | - | - | - | -164,026 | -100.00% | - | Mar 31, 2024 |
CORNERSTONE PLANNING GROUP LLC | - | - | - | -5 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Akari Therapeutics's biggest institutional seller is SABBY MANAGEMENT, LLC. The company sold -0.16M shares of AKTX, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SABBY MANAGEMENT, LLC | - | - | - | -164,026 | -100.00% | - | Mar 31, 2024 |
CORNERSTONE PLANNING GROUP LLC | - | - | - | -5 | -100.00% | - | Mar 31, 2024 |
Akari Therapeutics's largest sold out institutional shareholder by shares sold is SABBY MANAGEMENT, LLC, sold -0.16M shares, valued at -, as of undefined.
Akari Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.00% | 30,264 | - | - | Feb 29, 2024 |
TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 24,589 | - | - | Feb 29, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 1,512 | - | - | Feb 29, 2024 |
Akari Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 30.26K shares, compromising 0.00% of its total assets.
Akari Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 23 | 2 | 100.00% |
30 Sep, 23 | 1 | -93.75% |
30 Jun, 23 | 16 | 45.45% |
31 Mar, 23 | 11 | -26.67% |
31 Dec, 22 | 15 | 15.38% |
30 Sep, 22 | 13 | -7.14% |
30 Jun, 22 | 14 | 27.27% |
31 Mar, 22 | 11 | - |
31 Dec, 21 | 11 | -21.43% |
30 Sep, 21 | 14 | 16.67% |
30 Jun, 21 | 12 | - |
31 Mar, 21 | 12 | - |
31 Dec, 20 | 12 | 9.09% |
30 Sep, 20 | 11 | -42.11% |
30 Jun, 20 | 19 | 58.33% |
31 Mar, 20 | 12 | -7.69% |
31 Dec, 19 | 13 | 30.00% |
30 Sep, 19 | 10 | 11.11% |
30 Jun, 19 | 9 | -25.00% |
31 Mar, 19 | 12 | 71.43% |
31 Dec, 18 | 7 | -36.36% |
30 Sep, 18 | 11 | 10.00% |
30 Jun, 18 | 10 | 11.11% |
31 Mar, 18 | 9 | -52.63% |
31 Dec, 17 | 19 | 58.33% |
30 Sep, 17 | 12 | -20.00% |
30 Jun, 17 | 15 | 25.00% |
31 Mar, 17 | 12 | -25.00% |
31 Dec, 16 | 16 | -11.11% |
30 Sep, 16 | 18 | -10.00% |
30 Jun, 16 | 20 | 11.11% |
31 Mar, 16 | 18 | -5.26% |
31 Dec, 15 | 19 | 35.71% |
30 Sep, 15 | 14 | - |
As of 31 Dec 23, 2 institutions are holding Akari Therapeutics's shares, representing an increase of 100.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 23 | 164,031 | -7.89% |
30 Sep, 23 | 178,091 | -98.23% |
30 Jun, 23 | 10,076,550 | -0.44% |
31 Mar, 23 | 10,120,691 | 13.43% |
31 Dec, 22 | 8,922,318 | -11.78% |
30 Sep, 22 | 10,113,790 | 501.23% |
30 Jun, 22 | 1,682,178 | 6.75% |
31 Mar, 22 | 1,575,861 | 9.22% |
31 Dec, 21 | 1,442,780 | 18.20% |
30 Sep, 21 | 1,220,629 | -7.08% |
30 Jun, 21 | 1,313,647 | -11.08% |
31 Mar, 21 | 1,477,375 | -6.78% |
31 Dec, 20 | 1,584,758 | 9.47% |
30 Sep, 20 | 1,447,669 | -50.24% |
30 Jun, 20 | 2,909,034 | 26.06% |
31 Mar, 20 | 2,307,615 | -2.65% |
31 Dec, 19 | 2,370,463 | 9.45% |
30 Sep, 19 | 2,165,845 | -12.96% |
30 Jun, 19 | 2,488,461 | 5.36% |
31 Mar, 19 | 2,361,941 | 13.99% |
31 Dec, 18 | 2,072,086 | 1.03% |
30 Sep, 18 | 2,050,973 | 3.25% |
30 Jun, 18 | 1,986,386 | -8.92% |
31 Mar, 18 | 2,180,812 | -43.75% |
31 Dec, 17 | 3,877,213 | 57.23% |
30 Sep, 17 | 2,465,922 | -21.97% |
30 Jun, 17 | 3,160,176 | -6.41% |
31 Mar, 17 | 3,376,632 | -14.77% |
31 Dec, 16 | 3,961,951 | -1.08% |
30 Sep, 16 | 4,005,099 | -4.69% |
30 Jun, 16 | 4,202,288 | 11.83% |
31 Mar, 16 | 3,757,603 | 10.28% |
31 Dec, 15 | 3,407,302 | 28.73% |
30 Sep, 15 | 2,646,851 | - |
Akari Therapeutics (AKTX) has 164.03K shares outstanding as of 31 Dec 23, down -7.89% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 23 | 0.26% | 322.97% |
30 Sep, 23 | 0.29% | 0.11% |
30 Jun, 23 | 16.14% | 6.14% |
31 Mar, 23 | 16.21% | 7.94% |
31 Dec, 22 | 14.29% | 4.92% |
30 Sep, 22 | 17.04% | 212.12% |
30 Jun, 22 | 2.83% | 32.77% |
31 Mar, 22 | 2.94% | 30.49% |
31 Dec, 21 | 3.11% | 44.99% |
30 Sep, 21 | 2.63% | 22.54% |
30 Jun, 21 | 3.41% | 23.16% |
31 Mar, 21 | 3.84% | 7.71% |
31 Dec, 20 | 7.06% | 30.35% |
30 Sep, 20 | 4.82% | 5.14% |
30 Jun, 20 | 9.69% | 11.52% |
31 Mar, 20 | 9.17% | 7.59% |
31 Dec, 19 | 10.99% | 9.10% |
30 Sep, 19 | 10.99% | 4.58% |
30 Jun, 19 | 15.48% | 6.94% |
31 Mar, 19 | 14.94% | 8.69% |
31 Dec, 18 | 13.11% | 7.28% |
30 Sep, 18 | 13.42% | 7.91% |
30 Jun, 18 | 13.02% | 6.37% |
31 Mar, 18 | 14.29% | 2.01% |
31 Dec, 17 | 26.67% | 6.08% |
30 Sep, 17 | 20.94% | 2.91% |
30 Jun, 17 | 26.83% | 3.26% |
31 Mar, 17 | 28.67% | 2.53% |
31 Dec, 16 | 33.64% | 2.91% |
30 Sep, 16 | 34.01% | 2.67% |
30 Jun, 16 | 35.68% | 3.50% |
31 Mar, 16 | 31.91% | 3.81% |
31 Dec, 15 | 28.93% | 2.52% |
30 Sep, 15 | 33.86% | - |
As of 31 Dec 23, Akari Therapeutics is held by 0.26% institutional shareholders, representing a 322.97% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 23 | 1 | - |
30 Sep, 23 | - | -100.00% |
30 Jun, 23 | 6 | 100.00% |
31 Mar, 23 | 3 | -50.00% |
31 Dec, 22 | 6 | - |
30 Sep, 22 | 6 | - |
30 Jun, 22 | 6 | 100.00% |
31 Mar, 22 | 3 | - |
31 Dec, 21 | 3 | 50.00% |
30 Sep, 21 | 2 | -66.67% |
30 Jun, 21 | 6 | - |
31 Mar, 21 | 6 | 20.00% |
31 Dec, 20 | 5 | 25.00% |
30 Sep, 20 | 4 | -69.23% |
30 Jun, 20 | 13 | 85.71% |
31 Mar, 20 | 7 | -22.22% |
31 Dec, 19 | 9 | 12.50% |
30 Sep, 19 | 8 | 300.00% |
30 Jun, 19 | 2 | -71.43% |
31 Mar, 19 | 7 | 75.00% |
31 Dec, 18 | 4 | -20.00% |
30 Sep, 18 | 5 | 66.67% |
30 Jun, 18 | 3 | 200.00% |
31 Mar, 18 | 1 | -90.91% |
31 Dec, 17 | 11 | 120.00% |
30 Sep, 17 | 5 | -28.57% |
30 Jun, 17 | 7 | 600.00% |
31 Mar, 17 | 1 | - |
31 Dec, 16 | 1 | -50.00% |
30 Sep, 16 | 2 | -66.67% |
30 Jun, 16 | 6 | - |
31 Mar, 16 | 6 | -40.00% |
31 Dec, 15 | 10 | -28.57% |
30 Sep, 15 | 14 | - |
1 institutional shareholders have increased their position in AKTX stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 23 | 1 | - |
30 Sep, 23 | 1 | -50.00% |
30 Jun, 23 | 2 | - |
31 Mar, 23 | - | -100.00% |
31 Dec, 22 | 3 | 200.00% |
30 Sep, 22 | 1 | -50.00% |
30 Jun, 22 | 2 | 100.00% |
31 Mar, 22 | 1 | - |
31 Dec, 21 | 1 | -80.00% |
30 Sep, 21 | 5 | - |
30 Jun, 21 | - | -100.00% |
31 Mar, 21 | 2 | 100.00% |
31 Dec, 20 | 1 | -66.67% |
30 Sep, 20 | 3 | -25.00% |
30 Jun, 20 | 4 | 33.33% |
31 Mar, 20 | 3 | 200.00% |
31 Dec, 19 | 1 | - |
30 Sep, 19 | 1 | -66.67% |
30 Jun, 19 | 3 | 50.00% |
31 Mar, 19 | 2 | - |
31 Dec, 18 | - | -100.00% |
30 Sep, 18 | 3 | - |
30 Jun, 18 | 3 | - |
31 Mar, 18 | 3 | - |
31 Dec, 17 | 3 | -25.00% |
30 Sep, 17 | 4 | - |
30 Jun, 17 | 4 | 33.33% |
31 Mar, 17 | 3 | - |
31 Dec, 16 | 3 | -25.00% |
30 Sep, 16 | 4 | -33.33% |
30 Jun, 16 | 6 | 20.00% |
31 Mar, 16 | 5 | -16.67% |
31 Dec, 15 | 6 | - |
30 Sep, 15 | - | - |
1 institutional shareholders have reduced their position in AKTX stock as of 31 Dec 23 compared to 1 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 23 | 2 | 100.00% | 164,031 | -7.89% | 0.26% | 322.97% | 1 | - | 1 | - |
30 Sep, 23 | 1 | -93.75% | 178,091 | -98.23% | 0.29% | 0.11% | - | -100.00% | 1 | -50.00% |
30 Jun, 23 | 16 | 45.45% | 10,076,550 | -0.44% | 16.14% | 6.14% | 6 | 100.00% | 2 | - |
31 Mar, 23 | 11 | -26.67% | 10,120,691 | 13.43% | 16.21% | 7.94% | 3 | -50.00% | - | -100.00% |
31 Dec, 22 | 15 | 15.38% | 8,922,318 | -11.78% | 14.29% | 4.92% | 6 | - | 3 | 200.00% |
30 Sep, 22 | 13 | -7.14% | 10,113,790 | 501.23% | 17.04% | 212.12% | 6 | - | 1 | -50.00% |
30 Jun, 22 | 14 | 27.27% | 1,682,178 | 6.75% | 2.83% | 32.77% | 6 | 100.00% | 2 | 100.00% |
31 Mar, 22 | 11 | - | 1,575,861 | 9.22% | 2.94% | 30.49% | 3 | - | 1 | - |
31 Dec, 21 | 11 | -21.43% | 1,442,780 | 18.20% | 3.11% | 44.99% | 3 | 50.00% | 1 | -80.00% |
30 Sep, 21 | 14 | 16.67% | 1,220,629 | -7.08% | 2.63% | 22.54% | 2 | -66.67% | 5 | - |
30 Jun, 21 | 12 | - | 1,313,647 | -11.08% | 3.41% | 23.16% | 6 | - | - | -100.00% |
31 Mar, 21 | 12 | - | 1,477,375 | -6.78% | 3.84% | 7.71% | 6 | 20.00% | 2 | 100.00% |
31 Dec, 20 | 12 | 9.09% | 1,584,758 | 9.47% | 7.06% | 30.35% | 5 | 25.00% | 1 | -66.67% |
30 Sep, 20 | 11 | -42.11% | 1,447,669 | -50.24% | 4.82% | 5.14% | 4 | -69.23% | 3 | -25.00% |
30 Jun, 20 | 19 | 58.33% | 2,909,034 | 26.06% | 9.69% | 11.52% | 13 | 85.71% | 4 | 33.33% |
31 Mar, 20 | 12 | -7.69% | 2,307,615 | -2.65% | 9.17% | 7.59% | 7 | -22.22% | 3 | 200.00% |
31 Dec, 19 | 13 | 30.00% | 2,370,463 | 9.45% | 10.99% | 9.10% | 9 | 12.50% | 1 | - |
30 Sep, 19 | 10 | 11.11% | 2,165,845 | -12.96% | 10.99% | 4.58% | 8 | 300.00% | 1 | -66.67% |
30 Jun, 19 | 9 | -25.00% | 2,488,461 | 5.36% | 15.48% | 6.94% | 2 | -71.43% | 3 | 50.00% |
31 Mar, 19 | 12 | 71.43% | 2,361,941 | 13.99% | 14.94% | 8.69% | 7 | 75.00% | 2 | - |
31 Dec, 18 | 7 | -36.36% | 2,072,086 | 1.03% | 13.11% | 7.28% | 4 | -20.00% | - | -100.00% |
30 Sep, 18 | 11 | 10.00% | 2,050,973 | 3.25% | 13.42% | 7.91% | 5 | 66.67% | 3 | - |
30 Jun, 18 | 10 | 11.11% | 1,986,386 | -8.92% | 13.02% | 6.37% | 3 | 200.00% | 3 | - |
31 Mar, 18 | 9 | -52.63% | 2,180,812 | -43.75% | 14.29% | 2.01% | 1 | -90.91% | 3 | - |
31 Dec, 17 | 19 | 58.33% | 3,877,213 | 57.23% | 26.67% | 6.08% | 11 | 120.00% | 3 | -25.00% |
30 Sep, 17 | 12 | -20.00% | 2,465,922 | -21.97% | 20.94% | 2.91% | 5 | -28.57% | 4 | - |
30 Jun, 17 | 15 | 25.00% | 3,160,176 | -6.41% | 26.83% | 3.26% | 7 | 600.00% | 4 | 33.33% |
31 Mar, 17 | 12 | -25.00% | 3,376,632 | -14.77% | 28.67% | 2.53% | 1 | - | 3 | - |
31 Dec, 16 | 16 | -11.11% | 3,961,951 | -1.08% | 33.64% | 2.91% | 1 | -50.00% | 3 | -25.00% |
30 Sep, 16 | 18 | -10.00% | 4,005,099 | -4.69% | 34.01% | 2.67% | 2 | -66.67% | 4 | -33.33% |
30 Jun, 16 | 20 | 11.11% | 4,202,288 | 11.83% | 35.68% | 3.50% | 6 | - | 6 | 20.00% |
31 Mar, 16 | 18 | -5.26% | 3,757,603 | 10.28% | 31.91% | 3.81% | 6 | -40.00% | 5 | -16.67% |
31 Dec, 15 | 19 | 35.71% | 3,407,302 | 28.73% | 28.93% | 2.52% | 10 | -28.57% | 6 | - |
30 Sep, 15 | 14 | - | 2,646,851 | - | 33.86% | - | 14 | - | - | - |
Akari Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Akari Therapeutics's stock was made by Jacques Rachelle Suzanne on Jan 02 2024, selling - shares at - per share (valued at -).
Akari Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | 1 | - |
Q2 2024 | 11 | - | - |
Q1 2024 | - | 10 | - |
Q4 2023 | - | - | - |
Q2 2023 | - | 5 | - |
Q3 2022 | - | 1 | - |
Q2 2022 | - | 2 | - |
Q1 2022 | - | 3 | - |
Q2 2021 | - | 2 | - |
Q2 2020 | - | 2 | - |
Q1 2020 | - | 1 | - |
Q4 2019 | - | 1 | - |
Q3 2019 | - | - | - |
Q2 2019 | - | 3 | - |
Q3 2018 | - | 1 | - |
Q2 2016 | 6 | - | - |
Q1 2016 | 1 | 1 | 100.00% |
Q4 2015 | 4 | - | - |
Q3 2015 | 10 | 2 | 500.00% |
Q2 2015 | - | 6 | - |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Akari Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | - | - |
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q4 2023 | - | - | - |
Q2 2023 | - | - | - |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q2 2021 | - | - | - |
Q2 2020 | - | - | - |
Q1 2020 | - | - | - |
Q4 2019 | - | - | - |
Q3 2019 | - | - | - |
Q2 2019 | - | - | - |
Q3 2018 | - | - | - |
Q2 2016 | - | - | - |
Q1 2016 | - | - | - |
Q4 2015 | - | - | - |
Q3 2015 | 1 | - | - |
Q2 2015 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Akari Therapeutics's stocks.
Akari Therapeutics Peer Ownership
Ticker | Company |
---|---|
SLNO | Soleno Therapeutics, Inc. |
MGTA | Dianthus Therapeutics, Inc. |
ONCR | Oncorus, Inc. |
AXLA | Axcella Health Inc. |
PULM | Pulmatrix, Inc. |
HSTO | Histogen Inc. |
CAPR | Capricor Therapeutics, Inc. |
DFFN | CervoMed Inc. |
SCPS | Scopus BioPharma Inc. |
LABP | Landos Biopharma, Inc. |
SONN | Sonnet BioTherapeutics Holdings, Inc. |
PCSA | Processa Pharmaceuticals, Inc. |
ANEB | Anebulo Pharmaceuticals, Inc. |
SLRX | Salarius Pharmaceuticals, Inc. |
AKTX Ownership FAQ
Who Owns Akari Therapeutics?
Akari Therapeutics is owned by institutional shareholders (0.26%), insiders (38.21%), and public (61.52%). The largest institutional shareholder of Akari Therapeutics is SABBY MANAGEMENT, LLC (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Akari Therapeutics?
Akari Therapeutics's major institutional shareholders are SABBY MANAGEMENT, LLC, and CORNERSTONE PLANNING GROUP LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Akari Therapeutics shareholders are there?
As of Dec 2023, there are 2 institutional shareholders of Akari Therapeutics.
What percentage of Akari Therapeutics is owned by SABBY MANAGEMENT, LLC?
SABBY MANAGEMENT, LLC owns 0 shares of Akari Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).
What percentage of Akari Therapeutics is owned by CORNERSTONE PLANNING GROUP LLC?
As of Mar 2024, CORNERSTONE PLANNING GROUP LLC holds 0 shares of Akari Therapeutics (AKTX), compromising 0% of the company, valued at $0.